KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

KRAS mutations seem to indicate a poor outcome in Non-Small-Cell Lung Cancer (NSCLC) but such evidence is still debated. The aim of this planned ancillary study within the TAILOR trial was to assess the prognostic value of KRAS mutations in advanced NSCLC patients treated with platinum-based first-l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Marabese, Mirko, Ganzinelli, Monica, Garassino, Marina C., Shepherd, Frances A., Piva, Sheila, Caiola, Elisa, Macerelli, Marianna, Bettini, Anna, Lauricella, Calogero, Floriani, Irene, Farina, Gabriella, Longo, Flavia, Bonomi, Lucia, Fabbri, M. Agnese, Veronese, Silvio, Marsoni, Silvia, Broggini, Massimo, Rulli, Eliana
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2015
Schlagworte:
Clinical Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741822/
https://ncbi.nlm.nih.gov/pubmed/26416458
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge